AQEUD

This brand name is authorized in Nigeria.

Active ingredients

The drug AQEUD contains one active pharmaceutical ingredient (API):

1	Aripiprazole UNII 82VFR53I78 - ARIPIPRAZOLE
	It has been proposed that aripiprazole’s efficacy in schizophrenia and Bipolar I Disorder is mediated through a combination of partial agonism at dopamine D2 and serotonin 5-HT1A receptors and antagonism of serotonin 5-HT2A receptors.
	Read more about Aripiprazole

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-6028	Tablet	AQEUD 5 TABLETS TAB 5 mg 3x10	27 RNW-PP-268641 AQEUD 5 TABLETS ARIPIPRAZOLE Aripiprazole 5mg B4-6028 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 7/7/2022 LEOTETRA HEALTHCARE LTD, GIDA NA'ADADE NAIBAWA KANO KANO 8066471561 leotetranigltd@outlook.com PSYCHOTROPICS INDIA LTD, PLOT N0. 12 & 12A, INDUSTRIAL PARK-II, SALEMPUR, MEHDOOD - 2 HARIDWAR-249403, UTTARAKHAND, INDIA., India	31/10/2023
B4-6029	Tablet	AQEUD 10 TABLETS TAB 10 mg 3x10	43 RNW-PP-268659 AQEUD 10 TABLETS ARIPIPRAZOLE Aripiprazole 10mg B4-6029 Drugs Imported Products 3x10 Prescription Only Medicine (POM) 7/7/2022 LEOTETRA HEALTHCARE LTD, GIDA NA'ADADE NAIBAWA KANO KANO 8066471561 leotetranigltd@outlook.com PSYCHOTROPICS INDIA LTD, PLOT N0. 12 & 12A, INDUSTRIAL PARK-II, SALEMPUR, MEHDOOD - 2 HARIDWAR-249403, UTTARAKHAND, INDIA., India	31/01/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N05AX12	Aripiprazole	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AX Other antipsychotics
Discover more medicines within N05AX12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-6028, B4-6029